Pages that link to "Q36070574"
Jump to navigation
Jump to search
The following pages link to Mutant p53: one name, many proteins (Q36070574):
Displaying 50 items.
- VRK1 interacts with p53 forming a basal complex that is activated by UV-induced DNA damage (Q24329080) (← links)
- Clinical significance of T cell metabolic reprogramming in cancer (Q26741974) (← links)
- Oncogenic Intra-p53 Family Member Interactions in Human Cancers (Q26749382) (← links)
- Mutant p53 and ETS2, a Tale of Reciprocity (Q26765746) (← links)
- Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers (Q26766271) (← links)
- Mutant p53: One, No One, and One Hundred Thousand (Q26770576) (← links)
- Regulation of Mutant p53 Protein Expression (Q26770579) (← links)
- The Contrived Mutant p53 Oncogene - Beyond Loss of Functions (Q26772237) (← links)
- Chemoprevention of Breast Cancer by Dietary Polyphenols (Q26773449) (← links)
- Krüppel-like factor 17, a novel tumor suppressor: its low expression is involved in cancer metastasis (Q26776349) (← links)
- The mutational landscape of hepatocellular carcinoma (Q26777478) (← links)
- Non-autonomous overgrowth by oncogenic niche cells: Cellular cooperation and competition in tumorigenesis (Q26781414) (← links)
- Reactivating mutant p53 using small molecules as zinc metallochaperones: awakening a sleeping giant in cancer (Q26800059) (← links)
- Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. (Q26827810) (← links)
- The significance of genetics for cholangiocarcinoma development (Q26865749) (← links)
- The role of miRNAs in regulating gene expression networks (Q26992175) (← links)
- Tumor suppressor p53 and its gain-of-function mutants in cancer (Q27000754) (← links)
- Mechanisms of protein-folding diseases at a glance (Q27003095) (← links)
- Tumor suppressor p53 and its mutants in cancer metabolism (Q27010683) (← links)
- Uncovering the role of p53 splice variants in human malignancy: a clinical perspective (Q27015641) (← links)
- The role of tumor suppressor p53 in the antioxidant defense and metabolism (Q27027604) (← links)
- Small molecule compounds targeting the p53 pathway: are we finally making progress? (Q27027835) (← links)
- Caught in the cross fire: p53 in inflammation. (Q27692076) (← links)
- Interaction of p53 with the CCT complex promotes protein folding and wild-type p53 activity (Q28000133) (← links)
- p53 Proteoforms and Intrinsic Disorder: An Illustration of the Protein Structure-Function Continuum Concept (Q28079390) (← links)
- p53 as a Regulator of Lipid Metabolism in Cancer (Q28079393) (← links)
- Nuclear actions of insulin-like growth factor binding protein-3 (Q28080513) (← links)
- Discovering Che-1/AATF: a new attractive target for cancer therapy (Q28083510) (← links)
- Axin cancer mutants form nanoaggregates to rewire the Wnt signaling network (Q28274105) (← links)
- Dual targeted therapy with p53 siRNA and Epigallocatechingallate in a triple negative breast cancer cell model (Q28545864) (← links)
- Identification of genes that are essential to restrict genome duplication to once per cell division (Q28820756) (← links)
- p53 coordinates base excision repair to prevent genomic instability (Q28834500) (← links)
- Evaluation of the use of therapeutic peptides for cancer treatment (Q29048586) (← links)
- Dual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humans (Q30009087) (← links)
- Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice (Q30235460) (← links)
- NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma (Q30300214) (← links)
- Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5. (Q30313610) (← links)
- Formaldehyde cross-linking and structural proteomics: Bridging the gap. (Q30374721) (← links)
- DNA-binding protects p53 from interactions with cofactors involved in transcription-independent functions (Q30392650) (← links)
- More targets, more pathways and more clues for mutant p53. (Q30542607) (← links)
- Structural visualization of the p53/RNA polymerase II assembly (Q30832097) (← links)
- Detection of somatic mutations in tumors using unaligned clonal sequencing data (Q30839080) (← links)
- Inferring pathway dysregulation in cancers from multiple types of omic data (Q30980125) (← links)
- Cancer: A piece of the p53 puzzle (Q33360347) (← links)
- SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker (Q33576879) (← links)
- p53 mutation status is a primary determinant of placenta-specific protein 1 expression in serous ovarian cancers (Q33598887) (← links)
- Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy (Q33633277) (← links)
- Protein degradation rate is the dominant mechanism accounting for the differences in protein abundance of basal p53 in a human breast and colorectal cancer cell line (Q33657982) (← links)
- Degradation of mutant p53H175 protein by Zn(II) through autophagy. (Q33709136) (← links)
- The emerging role of QSOX1 in cancer (Q33828308) (← links)